CD4+CD25highCD226low/– cells: An innovative approach to identify human regulatory T cells - 04/02/21
![](/templates/common/images/mail.png)
![](/templates/common/images/mail.png)
Y.L. and G.Q.Y. were supported in part by grants from the Guangxi Science and Technology Base and Specialized Talent (grants 2017AD23009, 203030301808, and 203050101934). Y.L. and F.H. were supported in part by grants from Guangdong Introducing Innovative and Entrepreneurial Teams (grant 2016ZT06S252) and the General Program of the National Natural Science Foundation of China (grants 81671611 and 81871224). J.W. and S.G.Z. were supported in part by the National Institutes of Health (grant R01 AR059103, National Institutes of Health STAR Award, and grant R61 AR073409). |
|
Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 147 - N° 2
P. 767 - Febbraio 2021 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?